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Oxidative damage by free radicals has been implicated in the pathogenesis of vascular disease in diabetes and hypertension. In the
present study, the total antioxidant status in diabetic and hypertensive rats before and after treatment with garlic (Allium sativum)
was determined. The total serum antioxidants were measured by a modiﬁed method reported earlier by Miller and coworkers.
The reproducibility of the assay was conﬁrmed by determining standard curves for the known antioxidants: trolox (a stable analog
of vitamin E), glutathione and vitamin C with interassay correlation coeﬃcients (R2,n = 10 in triplicate) of 0.9984, 0.9768 and
0.987, respectively, conﬁrming the reliability and reproducibility of the assay. This assay was then used to determine total serum
antioxidant levels of streptozotocin-induced diabetic rats and two-kidney one-clip hypertensive rats both before and after 3 weeks
of treatment with an aqueous extract of garlic (500 mg/kg IP daily). The serum antioxidant levels of rats after 3 weeks of treatment
were signiﬁcantly higher (P < .001) than the pretreatment levels in both diabetic and hypertensive rats. The increased serum
antioxidant levels were paralleled by a decrease in serum glucose in the garlic-treated diabetic rats and lowered systolic blood
pressure in the garlic-treated hypertensive rats. We conclude from our study that (i) total antioxidants can be measured by a
simple, reproducible, reliable assay and (ii) the total antioxidant status can be signiﬁcantly improved by treatment with garlic.
1.Introduction
Oxidative stress, an excessive production of reactive oxy-
gen species (ROS) above the body’s antioxidant capacity,
has been implicated in the development of many patho-
physiological conditions including hypertension, diabetes,
atherosclerosis and cancer, as well as the process of aging
[1–6]. ROS are normal products of cellular metabolism
which are usually removed by endogenous antioxidants
[7]. However, it has become increasingly clear that over-
production of ROS can lead to a damaging cycle of lipid
peroxidation, depletion of natural antioxidants such as
glutathione, perturbation of nitric oxide production and
disruption of normal cellular metabolism [8]. These changes
have been shown to cause damage to cell membranes and in
particular can cause endothelial dysfunction [9].
Due to the importance of changes in the oxidant to
antioxidant ratio in relation to the development of patho-
logical conditions, the measure of antioxidant capacity of
serum has increasingly become used as an index of the
antioxidant status of the system. Markers of oxidative stress
that are commonly measured include: endogenous antiox-
idants such as glutathione, cysteine and antioxidant vita-
mins; antioxidant enzymes such as glutathione peroxidase,
myeloperoxidase and superoxide dismutase; F2-isoprostanes
and malondialdenyde as products of lipid peroxidation; and
end-products of protein oxidation such as nitrotyrosine [8,
10]. In addition, a number of in vitro spectrophotometric
assays have been developed to assess antioxidant capacity
including the quantitation of Trolox equivalent antioxidant
capacity[8,11].However,manyoftheseassaysarelaborious,
involvetheuseofdiﬃcultandunclearmethodologiesandare
expensive. In a recent review, Dalle-Donne and coworkers
have discussed the measurement and reliability of various
biomarkers in human disease [10].
Recent reports have suggested that diabetic complica-
tions and hypertension have a common etiology involving
oxidative stress and endothelial damage [9, 12, 13]. In fact,2 Evidence-Based Complementary and Alternative Medicine
the earliest pathological changes in diabetic complications
have been reported to be hemodynamic in nature [14–
16]. Thus, the assessment of oxidative stress in both dia-
betes and hypertension has become crucial as an index
of pathology of these diseases. In fact, many reports have
emphasized the common link between ROS levels and
severity of these conditions [17, 18]. In addition, antioxi-
dants have been shown to modulate oxidative stress-induced
changes in hypertension, atherosclerosis and diabetes [19,
20].
Duetotheincreasingworldwideprevalenceandﬁnancial
burden of chronic diseases such as diabetes and hyperten-
sion,ithasbecomeincreasinglyimportanttoﬁndpharmaco-
logicalremediestoalleviatethesymptomsandcomplications
of these conditions. In particular the use of natural remedies
such as garlic has become popular as both preventative and
treatment alternatives. Garlic has been extensively studied
and has been shown to have a number of medicinal
properties including antithrombotic [21–26], antibiotic [27–
29], hypolipidemic [30, 31], hypocholesteremic [30, 32],
hypoglycemic [33–39] and hypotensive [30, 40] activities.
Various garlic preparations and components have also been
shown to have antioxidant activity including the ability to
lower ROS in vivo [31, 41, 42].
In recent years, we have been studying the beneﬁcial
eﬀects of aqueous extracts of garlic in the treatment of
chronic diseases such as diabetes and hypertension [21, 23–
25, 30, 43, 44]. As part of this work, we found it necessary
to develop a method for measurement of oxidative stress.
Measurementof Trolox equivalentantioxidant capacity units
(TEAC) was developed by Miller, Rice-Evans and coworkers
as a method for measurement of antioxidant capacity
[45–47]. This is an electron-transfer method that exploits
the peroxidase activity of methemoglobin combined with
its interaction with a phenothiazine compound [azinobis-
(3-ethylbenzothiazoline-6-sulfonic acid), ABTS] to form a
radical cation intermediate (ABTS•+). The concentration
of antioxidants giving the same percentage change of
absorbance of ABTS•+ as that of 1mM Trolox is regarded
as a TEAC [48]. However, description of this method
lacked critical details necessary to its routine use. Therefore,
in the present study, the assay was modiﬁed for routine
measurement of antioxidant capacity of serum and was
appliedtotheassessmentofantioxidantlevelsindiabeticand
hypertensive rat models treated with garlic.
2.MaterialsandMethods
2.1. Materials. Streptozotocin, myoglobin (equine) and 2,2 -
azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) diam-
monium salt (ABTS) were purchased from Sigma Chem-
ical Co. (St Louis, MO, USA). Trolox (6-hydroxy-2,5,7,8-
tetramethylchronam-2-carboxylic acid) was purchased from
Aldrich Chemical Co. (Milwaukee, WI, USA). Vitamin C,
reduced glutathione and hydrogen peroxide were obtained
from Fluka (Buchs, Switzerland). Glucose oxidase kits were
obtainedfromWacoPureChemicalsCo.,Ltd(Osaka,Japan).
A l lo t h e rr e a g e n t sw e r eo fa n a l y t i c a lg r a d e .
2.2. Antioxidant Assay. Total antioxidant levels were mea-
sured by a modiﬁed Rice-Evans method [45–47]w h i c hi s
based on the inhibition by antioxidants of the absorbance of
the radical cation ABTS•+. The spectrophotometric method
derives from the observation that when ABTS is incubated
with a peroxidase (metmyoglobin) and hydrogen peroxide,
the relatively long-lived radical cation, ABTS•+,i sf o r m e d .
ABTS•+ has absorption maxima at 650, 734 and 820nm. In
the presence of antioxidants, the absorbance (at 734 nm) of
this radical cation is quenched to an extent and on a time
scale dependent on the antioxidant capacity of the material
under investigation.
Metmyoglobin (MetMb) was prepared by mixing myo-
globin with an oxidizing agent [K3Fe(CN6)] and then re-
puriﬁed on a G-25 column before use as described by Miller
and Rice-Evans [47]. The concentration of myoglobin in the
columneluatewascalculatedusingtheextinctioncoeﬃcients
of met-, oxy- and ferryl-myoglobin at 490, 560 and 580nm
using the following equation:
[MetMb](μM) = 146A490 −108A560 +2 .1A580.
P u r i ﬁ e dm y o g l o b i nw a ss t o r e di ns m a l la l i q u o t sa t−20◦C
until use.
The current modiﬁcation of the assay included changes
in the speciﬁcity of timing of the assay including a 3min
preincubation that are critical to the reproducibility of the
assay (Table 1). Three known antioxidants, vitamin C, trolox
(a stable analog of vitamin E) and glutathione, were used
to assess the reproducibility of the assay. The results are
calculated and expressed as TEAC.
2.3. Preparation of Garlic Extract. Aqueous garlic extract was
preparedfromlocallyavailablegarliccloves.Thegarliccloves
were peeled on crushed ice and 50g of garlic was cut into
small pieces and homogenized in 75mL of cold, sterile 0.9%
NaCl in the presence of some crushed ice. The homoge-
nization was carried out in a blender at high speed using
six 2-min bursts for a total of 12min. The homogenized
mixture was ﬁltered three times through cheesecloth. The
ﬁltrate was centrifuged at 2000 RCF for 10min and the clear
supernatant was made up to 100mL with normal saline. The
concentration of this garlic preparation was considered to be
500mg/mL on the basis of weight of the starting material
(50g/100 mL).
2.4.DiabetesInductionandSampleCollection. MaleSprague-
Dawleyratsweighing250–280gandmaintainedonanormal
diet and ﬁltered tap water ad libitum were used in the study.
All animal manipulations were conducted according to the
ethical guidelines outlined in the Guide for Care and Use of
LaboratoryAnimals[49].Forbaselinedata,bloodwasdrawn
from all animals by cardiac puncture under ether anesthesia
and allowed to clot. Immediately, the clotted blood was
centrifugedat2000RCFfor30min.Theserumwasseparated
a n ds t o r e da t– 8 0 ◦C for later analysis.
The animals were randomly divided into a normal
group (eight rats) and a streptozotocin (STZ)-treated group
(20 rats). The STZ-treated rats were injected with 60mgEvidence-Based Complementary and Alternative Medicine 3
Table 1: Protocol for the antioxidant assay.
Solution Blank
a (μL) Sample (μL)
PBS (5mM, pH 7.4, 138mM NaCl) 1000 – (105 + x) 1000 – (115 + x)
MetMb (as determined above) xb x
Sample (serum or antioxidant) — 10
ABTS (5mM) 30 30
Equilibrate for 3min at 30◦C
H2O2 (10mM) 75 75
Incubate for 6min at 30◦C
Read absorbance at 734nm after exactly 15s of incubation period completion
c
aRead against PBS buﬀer.
bMeMb concentration is determined experimentally and the required volume (x) is added to obtain 2.5μM ﬁnal concentration in the assay. The volume of
PBS buﬀer is adjusted accordingly.
cOnly six samples can be run at a time to ﬁt the timing protocol.
steptozotocin/kg body weight intraperitoneally (IP) in a
volume of 0.5mL saline according to the method of Axler
[50] following an overnight fast. After a period of 3 days,
blood was drawn from the STZ-treated animals by cardiac
puncture,andserumwaspreparedandstoredforlateranaly-
sis as described above. Serum glucose levels were determined
immediately and the STZ-treated rats determined to be
diabeticduetoahighserumglucoselevel(>350mg/dL)were
randomly divided into two groups containing eight animals
each: Group 1, the diabetic control group, was injected IP
daily with saline for the treatment period; and Group 2, the
garlic-treated group, was injected IP daily with 500mg/kg of
the garlic extract.
After a period of 3 weeks, the rats were sacriﬁced
under sodium pentobarbitone anaesthesia according to the
guidelines for euthanasia in the Guide for Care and Use
of Laboratory Animals [49]. Before sacriﬁce, blood was
collected, processed and stored at −80◦C for analysis within
1 week as described above.
2.5. Induction of Hypertension and Assessment. Ten male
Sprague-Dawley rats with initial body weight of 50g were
operated on to induce a two-kidney, one-clip (2K-1C) model
of hypertension as described earlier [51]. After 1 week,
hypertensionwasconﬁrmedbybloodpressuremeasurement
using the tail-cuﬀ method. The hypertensive rats were then
divided into two groups: ﬁve of the rats were treated daily
with 500mg/kg garlic IP for a period of 3 weeks and the
remaining ﬁve rats served as control and were given saline
IP for 3 weeks. Blood pressure was also measured at the
end of the treatment period by the tail-cuﬀ method. Blood
was drawn by cardiac puncture before and after 3 weeks
of treatment as described above and total antioxidant levels
were determined.
2.6. Assays. Serum glucose was quantitated spectrophoto-
metrically by the glucose oxidase method using kits from
Waco, (Japan). TEAC levels (mM) were determined as
described above. Systolic blood pressure was measured using
the tail-cuﬀ technique (Harvard Apparatus, England).
2.7. Statistical Analysis. The experimental data are expressed
as mean ± SEM. Statistical analysis was performed using
Minitab Statistical Software (Version 7, State College, PA,
USA). Data was analyzed using the two-sample T-test and
al e v e lo fP < .05 is considered to be signiﬁcant.
3. Results
3.1. Assessment of the Assay. The reproducibility of the
antioxidant assay was assessed by determination of the
inhibitory eﬀects of three known antioxidants, vitamin C,
glutathione and trolox (a stable analog of vitamin E). The
standard curve for each antioxidant was performed 8–10
times in triplicate. The standard curves in Figures 1(a)–
1(c) indicate that for all three known antioxidants good
reproducibilitywithintheconcentrationrangeswasobtained
using the assay. The inter-assay correlation coeﬃcients
(R2) were 0.9984, 0.9768 and 0.987 for trolox, glutathione
and vitamin C, respectively, conﬁrming the reliability and
reproducibility of the assay.
3.2.EﬀectsinDiabeticRats. Inductionofadiabeticstatewith
STZ led to marked hyperglycemia within 3 days of injection
(Table 1). This hyperglycemic state was accompanied by
signiﬁcantly decreased antioxidant levels (about 40% reduc-
tion) both 3 days and 3 weeks after STZ-injection (Figure 2).
In contrast, after 3 weeks, the diabetic rats given 500mg/kg
garlic daily recovered antioxidant activity reaching levels
in excess of those observed in normal rats. This increase
in serum antioxidant levels was paralleled by a decrease
in serum glucose levels as the garlic-treated diabetic rats
returned to an euglycemic state (Table 2).
3.3. Eﬀects in Hypertensive Rats. As shown in Figure 3,2 K -
1C hypertensive rats (systolic BP = 200 ± 17mm) exhibited
signiﬁcantly decreased total antioxidant levels compared to
normotensive rats (about 66% reduction). After 3 weeks of
garlic treatment, the antioxidant levels in the hypertensive
rats increased to about two-third of the normal levels,
while the antioxidant levels in the hypertensive control rats4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Standard curves for inhibition of ABTS+• absorbance at 734nm with (a) glutathione, (b) ascorbic acid (vitamin C) and (c)
trolox. Glutathione concentrations were between 0.5 and 2.5mM. Ascorbic acid concentrations were between 0.005 and 0.02mM. Trolox
concentrations were between 0.005 and 0.02mM. All assays were done in triplicate.
Table 2: Serum glucose concentration in diﬀerent animal groups.
Initial serum glucose (mg/dL) Final serum glucose (mg/dL)
Normal
a (saline treated) — 129 ± 9
Diabetic control
a (Saline treated) 400 ± 9 431 ± 13b
Garlic-treated diabetic
a (500mg/kg garlic) 400 ± 9c 237 ± 8c
an = 10 for all groups.
bSigniﬁcally diﬀerent compared to normal (P < .05).
cSigniﬁcally diﬀerent compared to initial and ﬁnal diabetic controls (P < .001).
continued to decrease (about 20% of the normotensive
level) during the 3-week experimental period. This increase
in antioxidant levels occurred simultaneously with a 50%
decrease in blood pressure (to 100 ± 22mm systolic) in the
2K-1C hypertensive rats.
4. Discussion
During the last decade, it has become increasingly evident
that many chronic diseases are accompanied by increased
levels of oxidative stress exacerbated by decreased antiox-
idant levels [10, 17, 52–54]. These observations have pre-
cipitated much interest in study of the correlations between
oxidative stress, antioxidant potential and development of
chronic diseases in both humans and animal models. Of
particular interest are the correlations between oxidative
stress and development of diabetes and hypertension [4, 5,
9, 55–57].
With the surge in research in this area, the development
ofsimple,reliableandconsistentmethodsforquantitationof
oxidative stress has become imperative. In particular, assays
for serum antioxidant levels have been developed including
measurement of total peroxy radical trapping as described
by Wayner et al. [58] and Rice-Evans and Miller [45–47].
Whereastheoriginalperoxyradicaltrappingparameterassay
of Wayner and coworkers [57] required an oxygen electrode
endpoint, Rice-Evans and Miller developed this assay to use
a spectrophotometric endpoint [45]. As described above,
this assay involves utilization of the peroxidase activity ofEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Antioxidant levels in diabetic rats. Normal, untreated
(control) diabetic and garlic-treated diabetic (diabetic garlic)
rats were assessed for antioxidant status (TEAC) 1 week after
STZ-injection (Post-STZ) and 3 weeks after treatment. (1) Total
antioxidants in normal rats are signiﬁcantly hgher than in diabetic
rats 3 days after induction of diabetes with STZ (P < .05). (2) Total
antioxidants in normal rats are signiﬁcantly higher than in diabetic
controlratsafter3weeks(P <.05).(3)Totalantioxidantsindiabetic
control rats are signiﬁcantly lower than in garlic-treated diabetic
rats after 3 weeks of garlic treatment (P < .05).
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methemoglobin, generation of the radical cation, ABTS•+,
and quantitation of the quenching of this radical cation
by antioxidants. Results are expressed in Trolox equivalent
antioxidant capacity using the vitamin E analog, Trolox, as
the reference antioxidant.
In the present study, we have modiﬁed the Rice-Evans
and Miller assay [46, 47] to include more precise timing
parameters including a 3-min pre-incubation, a 6-min
reaction time followed by absorbance measurement exactly
15s after stopping the inhibition reaction. These timing
parameters have allowed the assay to be conducted with the
u s eo fa3 0 ◦C water bath and a basic spectrophotometer. The
Rice-Evans and Miller manual assay [46] required the use of
atemperature-controlledcuvetteholderforcontinuousmea-
surement of absorbance. Thus, in the current modiﬁcation,
the assay involves pre-incubation of all reagents except H2O2
for 3min at 30◦C, addition of H2O2 at 15s intervals followed
by 6min incubation at 30◦C. The absorbance was then read
at exactly 15s intervals such that all assays were incubated
for exactly 6min. These timing parameters allowed six assays
to be carried out simultaneously. The 6min reaction time
is in agreement with that of van den Berg et al. [59]a n d
Re and coworkers [60], who also modiﬁed the assay to
eliminate the use of methemoglobin. In our hands, the
modiﬁcations described have allowed the routine use of this
assay for assessment of serum antioxidant levels. Standard
curves for three known antioxidants (gluathione, vitamin C
and Trolox) indicate that the assay is reproducible and stable
(Figures 1(a)–1(c)).
There has been considerable focus in recent years on the
connectionbetweenoxidativestressandendothelialdysfunc-
tion leading to the development of chronic conditions such
as diabetes and hypertension [5, 9, 13, 56, 61]. Endothelial
dysfunction is correlated with the development of coronary
heart disease and peripheral vascular resistance which are
the leading causes of morbidity and mortality in diabetes
mellitus [18, 62]. It has become increasingly evident that
the development of hyperglycemia followed by oxidative
stress is the underlying cause of the chronic complications of
diabetes.Therefore,thepreventionoralleviationofoxidative
stress in diabetes should positively beneﬁt the diabetic
patient.
Similarly, the development of hypertension has been
linked to impairment in the antioxidant defense system
[5, 56]. Similar to diabetes, hypertension, in particular ren-
ovascular hypertension, has been characterized by increased
oxidative stress and endothelial dysfunction [63]. Therefore,
numerous studies have focused on the correlation between
serum antioxidant levels and hypertension as well as the
alleviation of this chronic condition through increased
consumptionofantioxidantsandantioxidant-richfoods[64,
65].
Our results show that treatment of STZ-induced diabetic
rats with a raw garlic extract alleviates both hyperglycemia
and oxidative stress in these animals. These observations
are in agreement with those of Anwar and Meki [31]w h o
treated STZ-induced diabetic rats with garlic oil. In addition,
recently Zalejska-Fiolka and coworkers [66] reported that
garlic-fed rats also fed oxidized oil had improved antioxidant
status, less lipid peroxidation and fewer atherosclerotic
changes than in oxidized oil fed controls. Similarly, Souza
and coworkers [67] have reported that N-acetylcysteine
(NAC), a water-soluble compound found in garlic extracts,
improved high-sucrose diet-induced obesity in rats. NAC
treatment resulted in improved glucose tolerance and lipid
proﬁle, as well as decreased LDL-oxidation and serum
oxidative stress. Therefore, several studies have suggested
that garlic most likely exacerbates diabetes in animal models
through improved antioxidant status.
Therefore, we have shown the applicability of the TEAC
assay to the assessment of antioxidant status of diabetic6 Evidence-Based Complementary and Alternative Medicine
rats. It should be noted that the method described here
measures only water-soluble antioxidants. Therefore, the
results reported here do not include fat-soluble antioxidant
levels which also may be aﬀected by garlic treatment.
In previous studies, we have reported that the 2K-1C
rat model is characterized by the development of renal
hypertension accompanied by increased expression of two
isoforms of the Na/H exchanger (NHE-1 and-3) in both
kidneys and increased serum levels of PGE2 and TXB2
[43, 68]. Treatment of these rats with an aqueous extract
of garlic lowered blood pressure and NHE-1 expression in
the unclipped kidney [43]. In the present study, we have
observed that the development of renal hypertension in
the 2K-1C rat is accompanied by decreased levels of serum
antioxidants. The increased blood pressure and oxidative
stresswerealleviatedbyadministrationofanaqueousextract
of garlic. These results are in agreement with our earlier
observation that the hypotensive eﬀect of garlic is partially
mediated through the nitric oxide pathway in the 2K-1C
rat model conﬁrming the usefulness of garlic in decreasing
oxidative stress and hypertension [44].
5. Summary
From this study, the following conclusions can be stated.
A reliable and reproducible assay for determination of
total antioxidant levels in serum has been developed and
applied. Treatment of diabetic rats with garlic resulted in
signiﬁcantlyincreasedantioxidantandloweredglucoselevels
compared to untreated diabetic animals. Treatment of 2K-
1C hypertensive rats with garlic increased the total level of
antioxidants to about two-third of the normal level. Garlic-
treated 2K-1C hypertensive rats had signiﬁcantly higher total
antioxidant levels and lower systolic blood pressure than
untreated 2K-1C hypertensive rats.
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